{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:43Z","timestamp":1761129043632},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ERA-NET PathoGenomics","award":["ANR-08-PATH-003-01"],"award-info":[{"award-number":["ANR-08-PATH-003-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.072","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T16:16:05Z","timestamp":1351613765000},"page":"183-189","source":"Crossref","is-referenced-by-count":15,"title":["Functional impacts of the diversity of the meningococcal factor H binding protein"],"prefix":"10.1016","volume":"31","author":[{"given":"Eva","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Giorgini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala-Eddine","family":"Deghmane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2012.10.072_bib0005","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.072_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1574-6968.1993.tb06457.x","article-title":"Population genetics of a transformable bacterium: the influence of horizontal genetic exchange on the biology of Neisseria meningitidis","volume":"112","author":"Maiden","year":"1993","journal-title":"FEMS Microbiol Lett"},{"issue":"8","key":"10.1016\/j.vaccine.2012.10.072_bib0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0966-842X(02)02402-2","article-title":"The duality of virulence and transmissibility in Neisseria meningitidis","volume":"10","author":"Taha","year":"2002","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.072_bib0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"7240","key":"10.1016\/j.vaccine.2012.10.072_bib0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2012.10.072_bib0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.072_bib0035","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.072_bib0040","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2012.10.072_bib0045","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.42.9.4158-4163.2004","article-title":"Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000","volume":"42","author":"Taha","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2012.10.072_bib0050","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"Thompson","year":"2003","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.072_bib0055","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/emboj\/19.5.1068","article-title":"Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator","volume":"19","author":"Deghmane","year":"2000","journal-title":"EMBO J"},{"issue":"21","key":"10.1016\/j.vaccine.2012.10.072_bib0060","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.072_bib0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinform"},{"issue":"5459","key":"10.1016\/j.vaccine.2012.10.072_bib0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.072_bib0075","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jac\/dkl066","article-title":"Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice","volume":"57","author":"Zarantonelli","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.072_bib0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2958.1998.00876.x","article-title":"Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein","volume":"28","author":"Taha","year":"1998","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.072_bib0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J Mol Diagn"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.072_bib0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(11)70027-5","article-title":"From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak","volume":"11","author":"Caron","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2012.10.072_bib0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1042\/bst0300971","article-title":"Factor H family proteins: on complement, microbes and human diseases","volume":"30","author":"Zipfel","year":"2002","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.072_bib0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/653583","article-title":"Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France","volume":"202","author":"Deghmane","year":"2010","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.072_bib0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1469-0691.2008.01955.x","article-title":"Hyperinvasive genotypes of Neisseria meningitidis in France","volume":"14","author":"Zarantonelli","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.072_bib0110","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1128\/JCM.42.4.1460-1465.2004","article-title":"Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada","volume":"42","author":"Tsang","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"45","key":"10.1016\/j.vaccine.2012.10.072_bib0115","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.072_bib0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"Seib","year":"2011","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.072_bib0125","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein","volume":"18","author":"Lucidarme","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.10.072_bib0130","series-title":"Surveillance of invasive bacterial diseases in Europe 2008\/2009","author":"European Centre for Disease Prevention and Control","year":"2011"},{"issue":"7","key":"10.1016\/j.vaccine.2012.10.072_bib0135","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement","volume":"6","author":"Lewis","year":"2010","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T13:55:50Z","timestamp":1542635750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12015320"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}